全文获取类型
收费全文 | 600篇 |
免费 | 104篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 14篇 |
妇产科学 | 11篇 |
基础医学 | 52篇 |
口腔科学 | 6篇 |
临床医学 | 94篇 |
内科学 | 126篇 |
皮肤病学 | 47篇 |
神经病学 | 35篇 |
特种医学 | 87篇 |
外科学 | 89篇 |
综合类 | 6篇 |
现状与发展 | 1篇 |
预防医学 | 39篇 |
眼科学 | 9篇 |
药学 | 18篇 |
中国医学 | 1篇 |
肿瘤学 | 71篇 |
出版年
2024年 | 4篇 |
2023年 | 27篇 |
2022年 | 8篇 |
2021年 | 14篇 |
2020年 | 24篇 |
2019年 | 17篇 |
2018年 | 29篇 |
2017年 | 32篇 |
2016年 | 35篇 |
2015年 | 33篇 |
2014年 | 43篇 |
2013年 | 27篇 |
2012年 | 28篇 |
2011年 | 20篇 |
2010年 | 28篇 |
2009年 | 21篇 |
2008年 | 19篇 |
2007年 | 27篇 |
2006年 | 14篇 |
2005年 | 19篇 |
2004年 | 10篇 |
2003年 | 11篇 |
2002年 | 14篇 |
2001年 | 3篇 |
2000年 | 7篇 |
1999年 | 12篇 |
1998年 | 18篇 |
1997年 | 7篇 |
1996年 | 5篇 |
1995年 | 8篇 |
1994年 | 20篇 |
1993年 | 10篇 |
1992年 | 8篇 |
1991年 | 6篇 |
1990年 | 5篇 |
1989年 | 12篇 |
1988年 | 10篇 |
1987年 | 8篇 |
1986年 | 6篇 |
1985年 | 7篇 |
1984年 | 11篇 |
1983年 | 9篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1979年 | 2篇 |
1978年 | 5篇 |
1977年 | 4篇 |
1976年 | 2篇 |
1975年 | 5篇 |
排序方式: 共有714条查询结果,搜索用时 15 毫秒
21.
22.
Sung Yoon Cho Rimm Huh Mi Sun Chang Jieun Lee Younghee Kwun Se Hyun Maeng Su Jin Kim Young Bae Sohn Sung Won Park Eun-Kyung Kwon Sun Ju Han Jooyoun Jung Dong-Kyu Jin 《Journal of Korean medical science》2014,29(2):254-260
Hunter syndrome (or mucopolysaccharidosis type II [MPS II]) arises because of a deficiency in the lysosomal enzyme iduronate-2-sulfatase. Short stature is a prominent and consistent feature in MPS II. Enzyme replacement therapy (ERT) with idursulfase (Elaprase®) or idursulfase beta (Hunterase®) have been developed for these patients. The effect of ERT on the growth of Korean patients with Hunter syndrome was evaluated at a single center. This study comprised 32 patients, who had received ERT for at least 2 yr; they were divided into three groups according to their ages at the start of ERT: group 1 (<6 yr, n=14), group 2 (6-10 yr, n=11), and group 3 (10-20 yr, n=7). The patients showed marked growth retardation as they got older. ERT may have less effect on the growth of patients with the severe form of Hunter syndrome. The height z-scores in groups 2 and 3 revealed a significant change (the estimated slopes before and after the treatment were -0.047 and -0.007, respectively: difference in the slope, 0.04; P<0.001). Growth in response to ERT could be an important treatment outcome or an endpoint for future studies.
Graphical Abstract
相似文献23.
Jeff D. Overington Yao C. Huang Michael J. Abramson Juliet L. Brown John R. Goddard Rayleen V. Bowman Kwun M. Fong Ian A. Yang 《Journal of thoracic disease》2014,6(11):1586-1596
Chronic obstructive pulmonary disease (COPD) is a complex chronic lung disease characterised by progressive fixed airflow limitation and acute exacerbations that frequently require hospitalisation. Evidence-based clinical guidelines for the diagnosis and management of COPD are now widely available. However, the uptake of these COPD guidelines in clinical practice is highly variable, as is the case for many other chronic disease guidelines. Studies have identified many barriers to implementation of COPD and other guidelines, including factors such as lack of familiarity with guidelines amongst clinicians and inadequate implementation programs. Several methods for enhancing adherence to clinical practice guidelines have been evaluated, including distribution methods, professional education sessions, electronic health records (EHR), point of care reminders and computer decision support systems (CDSS). Results of these studies are mixed to date, and the most effective ways to implement clinical practice guidelines remain unclear. Given the significant resources dedicated to evidence-based medicine, effective dissemination and implementation of best practice at the patient level is an important final step in the process of guideline development. Future efforts should focus on identifying optimal methods for translating the evidence into everyday clinical practice to ensure that patients receive the best care. 相似文献
24.
25.
26.
Respiratory health effects of diesel particulate matter 总被引:1,自引:0,他引:1
Ristovski ZD Miljevic B Surawski NC Morawska L Fong KM Goh F Yang IA 《Respirology (Carlton, Vic.)》2012,17(2):201-212
Particulate matter (PM) emissions involve a complex mixture of solid and liquid particles suspended in a gas, where it is noted that PM emissions from diesel engines are a major contributor to the ambient air pollution problem. While epidemiological studies have shown a link between increased ambient PM emissions and respiratory morbidity and mortality, studies of this design are not able to identify the PM constituents responsible for driving adverse respiratory health effects. This review explores in detail the physico-chemical properties of diesel PM (DPM) and identifies the constituents of this pollution source that are responsible for the development of respiratory disease. In particular, this review shows that the DPM surface area and adsorbed organic compounds play a significant role in manifesting chemical and cellular processes that if sustained can lead to the development of adverse respiratory health effects. The mechanisms of injury involved included inflammation, innate and acquired immunity, and oxidative stress. Understanding the mechanisms of lung injury from DPM will enhance efforts to protect at-risk individuals from the harmful respiratory effects of air pollutants. 相似文献
27.
The Tumour, Node, Metastasis (TNM) system for classifying lung cancer is the cornerstone of modern lung cancer treatment and underpins comparative research; yet is continuously evolving through updated revisions. The recently published Union for International Cancer Control 7th Edition TNM Classification for lung cancer addresses many of its predecessor's shortcomings and has been subject to rigorous evidence-based methodology. It is based on a retrospective analysis of over 80 000 lung cancer patients treated between 1990 and 2000 carried out by the International Association for the Study of Lung Cancer. The dataset was truly international and included patients treated by all modalities. Extensive internal and external validation of the findings has ensured that the recommendations are robust and generalizable. For the first time, a single classification system has been shown to be applicable not only to non-small cell lung cancer, but also to be of prognostic significance in small cell lung cancer and bronchopulmonary carcinoid tumours. We review the history of the Union for International Cancer Control TNM staging system, the changes in the most recent 7th edition and the strength of the scientific basis motivating these changes. Limitations of the current staging edition are explored, post-publication independent validation studies are reviewed, and the future of TNM staging for lung cancer is discussed. 相似文献
28.
29.
30.
Miao Huang RN MSN Ruiqi Yang RN MSN Chuanlai Zhang RN BD Xiuni Gan RN MSN 《Nursing in critical care》2023,28(6):931-939